Cardiac resynchronization therapy for patients with heart failure and nonspecific intraventricular conduction delay

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Background:

• Cardiac resynchronization therapy (CRT) is recommended for heart failure (HF) patients with left bundle branch block (LBBB) per 2021 ESC Guidelines.
• Evidence supporting CRT efficacy in patients with non-LBBB (NICD) morphology is limited and controversial due to patient heterogeneity.

Purpose of the Study:

• To investigate the efficacy of CRT in heart failure patients with non-LBBB (NICD) morphology.
• To explore the potential role of His-Purkinje conduction system pacing (HPCSP) in managing these patients.

Main Methods:

• Systematic review of existing literature on CRT in HF patients with varying QRS morphologies.
• Analysis of patient subgroups with NICD to assess CRT response.
• Comparison of outcomes between LBBB and NICD groups.

Main Results:

• CRT demonstrates established efficacy in LBBB patients.
• Insufficient evidence currently supports CRT benefit for the heterogeneous NICD population.
• The role of HPCSP in NICD patients warrants further research.

Conclusions:

• While CRT is beneficial for LBBB patients, its application in NICD patients requires more robust evidence.
• Future research should focus on identifying predictors of response and exploring advanced pacing techniques like HPCSP in NICD patients.